Antagonists of the stress and opioid systems restore the functional connectivity of the prefrontal cortex during alcohol withdrawal through divergent mechanisms.

Chronic alcohol consumption leads to dependence and withdrawal symptoms upon cessation, contributing to persistent use. However, the brain network mechanisms by which the brain orchestrates alcohol withdrawal and how these networks are affected by pharmacological treatments remain elusive. Recent work revealed that alcohol withdrawal produces a widespread increase in coordinated brain activity and a decrease in modularity of the whole-brain functional network using single-cell whole-brain imaging of immediate early genes. This decreased modularity and functional hyperconnectivity are hypothesized to be novel biomarkers of alcohol withdrawal in alcohol dependence, which could potentially be used to evaluate the efficacy of new medications for alcohol use disorder. However, there is no evidence that current FDA-approved medications or experimental treatments known to reduce alcohol drinking in animal models can normalize the changes in whole-brain functional connectivity. In this report, we tested the effect of R121919, a CRF1 antagonist, and naltrexone, an FDA-approved treatment for alcohol use disorder, on whole-brain functional connectivity using the cellular marker FOS combined with graph theory and advanced network analyses. Results show that both R121919 and naltrexone restored the functional connectivity of the prefrontal cortex during alcohol withdrawal, but through divergent mechanisms. Specifically, R121919 increased FOS activation in the prefrontal cortex, partially restored modularity, and normalized connectivity, particularly in CRF1-rich regions, including the prefrontal, pallidum, and extended amygdala circuits. On the other hand, naltrexone decreased FOS activation throughout the brain, decreased modularity, and increased connectivity overall except for the Mu opioid receptor-rich regions, including the thalamus. These results identify the brain networks underlying the pharmacological effects of R121919 and naltrexone and demonstrate that these drugs restored different aspects of functional connectivity of the prefrontal cortex, pallidum, amygdala, and thalamus during alcohol withdrawal. Notably, these effects were particularly prominent in CRF1- and Mu opioid receptors-rich regions highlighting the potential of whole-brain functional connectivity using FOS as a tool for identifying neuronal network mechanisms underlying the pharmacological effects of existing and new medications for alcohol use disorder.

Differentiation between alcohol-associated cirrhosis and hepatitis B-associated cirrhosis based on hepatic complications and psychological symptoms.

Background: The prognosis of and occurrence of complications in patients with different clinical features of cirrhosis differ, and cirrhosis with different etiologies has varying clinical characteristics. The aim of this study was to describe the liver function markers, hepatic complications, and psychological features differentiating patients with hepatitis B virus (HBV) infection-related and alcohol-related cirrhosis. Materials and Methods: This was a retrospective and observational study that analyzed the medical data of inpatients with alcohol-related or HBV infection-related cirrhosis from May 2014 to May 2020. Markers of liver function, portal hypertension, and psychological symptoms were compared between the two groups. Results: Patients with alcohol-related cirrhosis showed higher Self-Rating Anxiety Scale scores and prevalence of hypoproteinemia, fatty liver, and depression than those with HBV infection-related cirrhosis (all P < 0.05). After adjustment for potential confounders, patients with alcohol-related cirrhosis also showed higher risks of increased total cholesterol (odds ratio [OR] =2.671, 95% confidence interval [CI]: 1.160-6.151, P = 0.021), increased high-density lipoprotein-cholesterol (OR = 2.714, 95% CI: 1.009-7.299, P = 0.048), and fatty liver (OR = 2.713, 95% CI: 1.002-7.215, P = 0.048); however, splenomegaly and splenectomy were significantly associated with HBV infection-related cirrhosis (OR = 2.320, 95% CI: 1.066-5.050, P = 0.034). Conclusion: Patients with alcohol-related cirrhosis were more likely to develop hyperlipidemia, fatty liver, and psychological symptoms, whereas those with HBV-related cirrhosis had a higher risk of splenomegaly.

Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study.

We assessed long-term mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department (ED) because of acute alcoholic intoxication (AAI). A retrospective cohort study was performed at the ED of Sant'Orsola-Malpighi Hospital, Bologna, Italy. 3304 patients, corresponding to 6415 admissions for AAI, who accessed the ED from January 1, 2005, to December 31, 2017, were studied. The ED electronic registry system was used to assess living status on 08 May 2020 and to obtain the prespecified potential predictors, i.e., age at first admission, sex, alcohol use disorder (AUD), substance use disorder (SUD), more than 1 admission to ED for trauma, mental and behavioral disorders, neurological disorders, and cardiovascular disease. The median follow-up time was 9.3 years and the time on risk was 30,053 person years (PY) with a death rate corresponding to 4.42 (95% CI 3.74-5.26) per 1000 PY (n = 133 deaths). The death rate was higher in patients with AUD (17.30) than in those without AUD (1.98) and in those with SUD (13.58) than in those without SUD (3.80). Lastly, there was a clearly higher death rate among AUD+ SUD+ (20.89) compared to AUD-SUD-patients (1.74). At multivariable Cox regression, AUD, SUD, and liver cirrhosis were strong and independent predictors of time-to-death. Using standardized mortality ratios, a clear excess of mortality was evident for all the age bands from (40-45] to (60-65] years. Mortality is higher in AAI than in the general population and chronic alcohol-related diseases are strongly associated with it.

Evaluation of the prevalence of the most common psychiatric disorders in patients with type 2 diabetes mellitus using the patient health questionnaire: results of the cross-sectional "DIA2PSI" study.

AIMS: Common Psychiatric Disorders (CPDs) are associated with the development of overweight and obesity, the strongest risk factors for the onset and maintenance of Type 2 Diabetes mellitus (T2D). To the best of our knowledge, this is the first study to assess the prevalence of CPDs in patients with T2D in Italy. METHODS: This is a monocentric cross-sectional study; n = 184 T2D patients were screened for CPDs using the Patient Health Questionnaire (PHQ). Primary outcome was to evaluate the prevalence of CPDs. To assess association between CPDs and risk factors, we have utilized univariable logistic regression models. RESULTS: 64.1% were men, median age was 67 (59-64) and median BMI 27 (25-30) kg/m2. The 42.9% tested positive for one or more mental disorders, 25.6% for depression. Patients with higher BMI (p = 0.04) had an increased likelihood of testing positive to the PHQ. Patients who had implemented lifestyle changes (p < 0.01) and were aware that mental health is linked to body health (p = 0.07) had a reduction in the likelihood of testing positive. CONCLUSIONS: Prevalence of CPDs in T2D patients is higher than in the general population. Since CPDs favor the onset and subsistence of T2D, integrated diabetic-psychiatric therapy is required for improvement or remission of T2D in patients with comorbid CPDs.

The Current State of Alcohol Screening and Management in Virginia Primary Care Practices: An Evaluation of Preventive Service Use.

The US Preventive Services Task Force (USPSTF) recommends screening and behavioral counseling for adults over 18 years for unhealthy alcohol use. Recommended screening instruments include the Alcohol Use Disorders Identification Test-Concise and or Single Alcohol Screening Question. Behavioral counseling is feasible in primary care, taking on average 30 minutes. Baseline data for a practice facilitation trial demonstrated clinicians appropriately screened only 10.8% of patients and only identified 9.6% as having risky drinking. Yet, 24% of patients reported risky drinking on a survey, demonstrating the implementation gap of the USPSTF recommendation and opportunity to improve health.

Advances in the crosstalk between maternal separation and voluntary ethanol consumption and effects on reproduction.

Maternal separation (SM) is an event caused by early stress and may be associated with behavioral changes and vulnerabilities, enhancing ethanol consumption in adulthood. The aim of the study was to evaluate whether MS potentiates the effects of ethanol ingestion on physiological hormone regulation and its interference in testicular and epididymal morphofunctional aspects in voluntary ethanol-consuming rats. Therefore, for the first time, we investigated the effect of maternal separation and ethanol consumption in adulthood and for this we used free choice ethanol-consuming strains. Responses of metabolic and hormonal parameters were also addressed, as well as their effects on reproductive function. In summary, MS promoted an increase in voluntary ethanol consumption in UChA and UChB animals. There was an influence of MS on the increase of circulating corticosterone and testosterone in UChB animals (high-ethanol-preferring 10 % v/v). MS performed in the hyporesponsive period to stress promoted an increase in glucose and circulating lipids, as well as a reduction in lactate dehydrogenase levels. Daily sperm production and transit time through the epididymis in UChB animals were increased by MS. Together, these findings show that MS potentiates the effects of ethanol ingestion and promotes an imbalance in plasma hormone concentrations, interfering with the reproductive functional imbalance of ethanol-consuming rats.

Síndrome hepatorrenal en asociación con hepatitis alcohólica y síndrome de Zieve / Hepatorenal syndrome in association with alcoholic hepatitis and Zieve's syndrome

RESUMEN La enfermedad hepática alcohólica tiene un amplio espectro de enfermedades, incluida la hepatitis alcohólica, que en sus formas graves puede conducir al síndrome hepatorrenal. La anemia es común en pacientes alcohólicos, pero una anemia hemolítica asociada con hiperlipidemia e ictericia se reconoce como síndrome de Zieve. Un varón de 42 años con consumo excesivo de alcohol fue admitido por ictericia y dolor abdominal. Durante su evolución presentó azoemia progresiva y anemia hemolítica. Se realizó el diagnóstico de síndrome hepatorrenal asociado a hepatitis alcohólica, así como un síndrome de Zieve. Fue tratado con corticoterapia y la combinación de albúmina y noradrenalina, además del retiro de alcohol, con resultados favorables.

ABSTRACT Alcoholic liver disease has a broad spectrum of diseases, including alcoholic hepatitis, which in its severe forms can lead to hepatorenal syndrome. Anemia is common in alcoholic patients, but a hemolytic anemia in association with hyperlipidemia and jaundice is recognized as Zieve's syndrome. A 42 year old man with heavy alcohol consumption was admitted for jaundice and abdominal pain. During his evolution, he presented progressive azotemia and hemolytic anemia. The diagnosis of hepatorenal syndrome associated with alcoholic hepatitis was made, as well as a Zieve's syndrome. He was treated with corticosteroid therapy and the combination of albumin and norepinephrine, in addition to alcohol withdrawal, with favorable results.

A retrospective evaluation of phenobarbital versus benzodiazepines for treatment of alcohol withdrawal in a regional Canadian emergency department.

Evidence suggests that phenobarbital can be used to treat alcohol withdrawal syndrome as monotherapy; however, the therapeutic cornerstone remains benzodiazepines. To date, studies comparing the two treatment modalities in the emergency department (ED) are few. We sought to determine whether phenobarbital versus benzodiazepine monotherapy impacts ED length of stay and need for admission among adult presentations at a single regional hospital. In June 2019, a treatment algorithm offering both phenobarbital and diazepam pathways was introduced at the Battlefords Union Hospital ED, an 11-bed unit treating 27 000 patients annually in North Battleford, Saskatchewan, Canada. A subsequent retrospective observational study evaluated all adult alcohol withdrawal syndrome presentations between June 2019 and January 2021. Medical records were reviewed for visit date, age, sex, comorbidities, psychosocial factors, Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scores, secondary diagnoses, time of day, protocol adherence, attending physician, length of stay, disposition, and ED return. Descriptive statistics, log-rank testing, simple regression, and multiple regression were used in analysis. Of the 184 presentations, 30.4% were treated with phenobarbital. Median length of stay for phenobarbital versus benzodiazepine therapy was 4.4 h and 4.4 h, respectively (p = 0.21). Of the phenobarbital presentations, 9.4% were hospitalized versus 17.1% of the benzodiazepine presentations (p = 0.20). When adjusted for confounders, phenobarbital-treated presentations were 71.3% less likely to be admitted (p = 0.03). This research suggests that phenobarbital performs similarly to benzodiazepines regarding alcohol withdrawal ED length of stay and may result in reduced hospitalizations.

Consumo moderado de alcohol y prevención de la depresión. Una revisión crítica / Moderate alcohol consumption and depression prevention. A critical review

Introducción. Hay un claro consenso en torno a que los trastornos por uso de alcohol se asocian con una mayor incidencia y peor pronóstico de depresión, además de otros problemas médicos. Sin embargo, se está planteando que el consumo de alcohol moderado previene y mejora la evolución de algunas enfermedades crónicas, especialmente cardiovasculares. No obstante, otros investigadores sugieren que no hay un consumo seguro de alcohol debido a sus efectos globales sobre la salud (aumento del riesgo de cáncer, por ejemplo). En relación a la depresión, también hay evidencia dispar sobre el posible efecto antidepresivo del consumo moderado de alcohol. Esta revisión crítica intenta resumir dicha evidencia, así como analizar la posible influencia relativa de factores involucrados. Metodología. Se realizó una búsqueda a través de PubMedncon las siguientes palabras claves y operadores booleanos: (“light alcohol” OR “light drinking” OR “moderate alcohol” OR “moderate drinking” OR “low risk drinking” OR “low risk alcohol”) AND (depress*) NOT (dependence OR abuse). Resultados. La mayoría de los 24 estudios seleccionados fueron longitudinales. El consumo moderado de alcohol se asocia a menor sintomatología depresiva en la mayoría de los estudios. Sin embargo, estos estudios no descartan que esta asociación pueda explicarse alternativamente por importantes factores de confusión no causales (estado de salud, comportamiento prosocial, otros factores de estilo de vida relacionados, etc.). Conclusiones. No hay evidencia científica clara y consistente actual que respalde el consumo moderado de alcohol per se como factor protector frente a la depresión.(AU)

Background. There is a clear consensus that alcohol use disorders are associated with poorer outcomes concerning depression, and that drinking alcohol shouldn`t be recommended because of the risk of dependence. Until recently, literature focused almost exclusively on patients with alcohol use disorders and excludes patients with moderate alcohol use (MAU). It’s has been shown that MAU can prevent or improve the evolution of chronic diseases such as cardiovascular diseases, but several researchers have suggested that there is no safe level of alcohol drinking due to other effects on health. Nevertheless, there is some evidence regarding the antidepressant effect of moderate alcohol consumption. This critical review aims to sum up the direction and tendency of current research on the effect of MAU on depression and relate the causal or confounders factors that might explain the results. Methods. A research was carried out through PubMed with the following keywords and Boolean operators: (“light alcohol” OR “light drinking” OR “moderate alcohol” OR “moderate drinking” OR “low risk drinking” OR “low risk alcohol”) AND (depress*) NOT (dependence OR abuse). Results. Most of the 23 studies selected aim to investigate longitudinal effects. MAU prevents depressive symptoms in most studies, but it is still unclear to what extent this can be alternatively explained by neurochemical factors or other confounding factors (health status, sociability, other related lifestyle factors, etc.). Conclusion. There is currently no clear and consistent scientific evidence to support moderate alcohol consumption per se as a protective factor against depression.(AU)

Hospitalization due to mental and behavioral disorders caused by use of alcohol and psychoactive substances among older adults and elderly people in Brazil: a cross-sectional study

ABSTRACT BACKGROUND: It has been estimated that 17% of individuals aged 50 years or older suffer from addiction to legal or illegal drugs. Use of alcohol and psychoactive substances has been correlated with several diseases, e.g. psychiatric conditions and cardiovascular and sexual dysfunctions. Objective: To discuss the Brazilian profile of mental and behavioral disorders caused by use of alcohol and psychoactive substances among older adults and elderly people, over the period from 2008 to 2019. DESIGN AND SETTING: Cross-sectional study conducted among Brazilians aged 50 years or older. METHODS: Hospitalization due to mental and behavioral disorders caused by use of alcohol and psychoactive substances was assessed through data obtained from the National Health System Department of Informatics (Departamento de Informática do Sistema Único de Saúde, DATASUS). RESULTS: Decreasing and steady trends of hospitalization due to mental and behavioral disorders caused by use of alcohol among both men and women at all ages were observed. Similar trends were reported for all age ranges among men and women aged 60 years and older. In contrast, a slight increase was seen among women aged 50 to 59 years. CONCLUSION: These data are crucial for qualifying mental healthcare for older adults and elderly people and for planning mental health services.

Efficacy of a theory-driven program to implement alcohol screening and brief interventions in primary health-care: a cluster randomized controlled trial.

BACKGROUND AND AIMS: Screening and brief interventions (SBI) in primary health-care practices (PHCP) are effective in reducing reported alcohol consumption, but have not been routinely implemented. Most programs seeking to improve implementation rates have lacked a theoretical rationale. This study aimed to test whether a theory-based intervention for PHCPs could significantly increase alcohol SBI delivery. DESIGN: Two-arm, cluster-randomized controlled, parallel, 12-month follow-up, trial. SETTING: PHCPs in Portugal. PARTICIPANTS: Staff from 12 PHCPs (n = 222, 81.1% women): nurses (35.6%), general practitioners (28.8%), receptionists (26.1%) and family medicine residents (9.5%); patients screened for alcohol use: intervention n = 8062; controls n = 58. INTERVENTION AND COMPARATOR: PHCPs were randomized to receive a training and support program (n = 6; 110 participants) tailored to the barriers and facilitators for implementing alcohol SBIs following the principles of the Behavior Change Wheel/Theoretical Domains Framework approach, or to a waiting-list control (n = 6; 112 participants). Training was delivered over the first 12 weeks of the trial. MEASUREMENTS: The primary outcome was the proportion of eligible patients screened (unit of analysis: patient list). Secondary outcomes included the brief intervention (BI) rate per screen-positive patient and the population-based BI rate (unit of analysis: patient list), and changes in health providers' perceptions of barriers to implementation and alcohol-related knowledge (unit of analysis: health provider). FINDINGS: The implementation program had a significant effect on the screening activity in the intervention practices compared with control practices at the 12-month follow-up (21.7% vs. 0.16%, intention-to-treat analysis, p = 0.003). Although no significant difference was found on the BI rate per screen-positive patient (intervention 85.7% vs. control 63.6%, p = 0.55, Bayes factor = 0.28), the intervention was effective in increasing the population-based BI rate (intervention 0.69% vs. control 0.02%, p = 0.006). Health providers in the intervention arm reported fewer barriers to SBI implementation and higher levels of alcohol-related knowledge at 12-month follow-up than those in control practices. CONCLUSION: A theory-based implementation program, which included training and support activities, significantly increased alcohol screening and population-based brief intervention rates in primary care.

Portuguese Validated Versions of the Alcohol Use Disorders Identification Test: A Systematic Review Protocol.

INTRODUCTION: Alcohol consumption ranks among the top ten risk factors contributing to the global disease burden. Several international organizations recommend the use of the Alcohol Use Disorders Identification Test to screen for at-risk drinkers. However, a fully validated Portuguese version of this test is lacking. The aim of this study is to systematically review validated versions of the Alcohol Use Disorders Identification Test in the Portuguese language, the documented problems and solutions in its application and proposed cut-offs to identify at-risk drinkers. MATERIAL AND METHODS: A systematic search will be performed in Ovid MEDLINE, CINAHL, PsycINFO, ÍndexRMP, LILACS, African Journals Online and SciELO databases, along with grey literature searches to identify validation studies of the AUDIT in Portuguese. Two authors will independently extract data and assess the studies' methodological quality, using QUADAS-2 and CASP checklists. DISCUSSION: This review will compare different validation studies of the Alcohol Use Disorders Identification Test in Portuguese-speaking countries, reporting, where possible, the psychometric properties, performance characteristics, suggested cut-offs and any documented limitations and suggestions. The results of this review could be used to propose an update of the alcohol screening and brief intervention guidelines in Portugal. The results could also prove useful to support the implementation of alcohol screening delivery by healthcare providers in Portugal and other official Portuguese-speaking countries. CONCLUSION: This review will provide important information on the validity of the Alcohol Use Disorders Identification Test as a screening tool for at-risk drinking in Portugal and other official Portuguese speaking countries.

Introdução: O consumo de álcool é um importante fator de risco modificável. Várias organizações internacionais recomendam a utilização do Alcohol Use Disorders Identification Test para identificar consumidores excessivos de álcool. No entanto, não parece haver uma versão totalmente validada deste questionário em português. O objetivo deste estudo é identificar versões validadas do Alcohol Use Disorders Identification Test em português, problemas e soluções na sua aplicação, e pontos de corte para identificar consumidores excessivos. Material e Métodos: Será realizada uma revisão sistemática dos estudos de validação do AUDIT em português existentes nas bases de dados Ovid MEDLINE, CINAHL, PsycINFO, ÍndexRMP, LILACS, African Journals Online e SciELO, bem como na literatura cinzenta. Dois autores extrairão informação, e avaliarão a qualidade dos estudos selecionados, de forma independente, utilizando as grelhas QUADAS-2 e CASP. Discussão: Esta revisão irá comparar estudos de validação do Alcohol Use Disorders Identification Test em português e reportar, se descrito, propriedades psicométricas, características de desempenho, pontos de corte sugeridos, limitações e sugestões documentadas. Os resultados poderão ser importantes para propor uma revisão da norma de orientação clínica portuguesa sobre o rastreio e intervenções breves nos consumidores de álcool. Por outro lado, os resultados poderão ser utilizados para apoiar a implementação do rastreio do consumo de álcool na prática clínica em Portugal e noutros países de língua oficial portuguesa. Conclusão: Esta revisão irá fornecer informação relevante sobre a validade do Alcohol Use Disorders Identification Test como método de rastreio do consumo excessivo de álcool em Portugal e noutros países de língua oficial portuguesa.

Risperidone combined with diazepam for the treatment of alcohol-induced mental and behavioral disorders / 中国基层医药

Objective:To investigate the clinical efficacy of risperidone combined with diazepam in the treatment of alcohol-induced mental and behavioral disorders.Methods:Sixty patients with alcohol-induced mental and behavioral disorders admitted to Huainan Psychiatric Hospital from January 2018 to January 2022 were included in this study. They were randomly assigned to undergo either diazepam alone (control group, n = 30) or risperidone combined with diazepam (study group, n = 30). Clinical efficacy, Positive and Negative Syndrome Scale (PANSS) score, incidence of adverse reactions, quality of life, treatment satisfaction were compared between the two groups. Results:Total response rate differed significantly between the two groups ( Z = 6.25, P < 0.05). In the control group, PANSS scores measured before and after treatment were as follows: positive symptoms: (26.07 ± 3.70) points vs. (16.38 ± 2.04) points; negative symptoms: (24.04 ± 2.98) points vs. (13.86 ± 1.84) points; psychopathological symptoms: (44.06 ± 5.28) points vs. (31.83 ± 4.04) points; general score: (91.84 ± 9.76) points vs. (40.84 ± 6.26) points. In the study group, PANSS scores measured before and after treatment were as follows: positive symptoms: (25.84 ± 3.82) points vs. (10.30 ± 1.17) points; negative symptoms: (24.48 ± 3.26) points vs. (7.48 ± 0.82) points; psychopathological symptoms: (43.28 ± 5.21) points vs. (21.06 ± 3.72) points; general score: (92.06 ± 9.85) points vs. (68.27 ± 7.02) points. There were no significant differences in above indices measured before treatment between the two groups (all P > 0.05). After treatment, scores of positive, negative, psychopathological symptoms and general scores in the study group were significantly lower than those in the control group ( t = 14.16, 17.34, 10.74, 15.97, all P < 0.001). There was no significant difference in the incidence of adverse reactions between the two groups ( P > 0.05). Before and after treatment, the quality of life scores (physiological, psychological, social and environmental scores) of the control group were (12.64 ± 2.50) points vs. (13.87 ± 2.16) points; (12.47 ± 2.12) points vs. (13.28 ± 2.18) points; (9.54 ± 2.16) points vs. (14.20 ± 1.27) points; (10.97 ± 1.84) points vs. (12.78 ± 2.42) points. Before and after treatment, the quality of life scores (physiological, psychological, social and environmental scores) of the study group were (12.68 ± 2.53) points vs. (15.37 ± 2.07) points; (12.49 ± 2.14) points vs. (14.90 ± 2.20) points; (9.37 ± 2.14) points vs. (15.03 ± 1.27) points; (10.94 ± 1.81) points vs. (13.86 ± 2.18) points. After treatment, physiological, psychological, social and environmental scores in the study group were significantly higher than those in the control group ( t = 2.74, 2.86, 2.50, 2.81, all P < 0.001). There was significant difference in treatment satisfaction between the two groups ( χ2 =5.19, P = 0.022). Conclusion:Risperidone combined with diazepam can help improve the clinical symptoms of patients with alcohol-caused mental and behavioral disorders, further improves the treatment effect and quality of life, and is safe.

Pérdida auditiva y consumo de alcohol en mujeres entre 20 y 40 años de edad, en la comuna de Temuco, Chile / Hearing loss and alcohol consumption in women between 20 and 40 years of age, in the commune of Temuco, Chile / Perda auditiva e consumo de álcool em mulheres entre 20 e 40 anos, na comuna de Temuco, Chile

Resumen Objetivo: Analizar la diferencia en la pérdida auditiva según el consumo de alcohol, en mujeres de entre 20 y 40 años de edad, en la comuna de Temuco, Chile. Metodología: Estudio de corte, donde se evaluaron 30 mujeres consumidoras y no consumidoras de alcohol, divididas en 3 grupos (G): G1 abstemias, G2 consumidoras de 40-59 y G3 consumidoras demás de 60g de alcohol diarios (15, 6 y 9 respectivamente), con un muestreo intencional, contactadas en centros comerciales. Se realizaron pruebas auditivas: audiometría, discriminación de la palabra y potenciales evocados auditivos de tronco cerebral. Resultados: El oído derecho presentó diferencias significativas en las frecuencias medias y discriminación de la palabra en G1 vs. G2 (p = 0,045 y 0,010, respectivamente). El oído izquierdo mostró diferencias significativas en las frecuencias agudas en G1 vs. G3, en las latencias interpeakde las ondas iii-v (tiempo en milisegundo transcurrido entre la onda iii y v posterior al estímulo) en G1 vs. G2 (p = 0,003) y G2 vs. G3 (p = 0,005) a 80 dB; en las latencias interpeaki-iiiy iii-v en G1 vs. G2 (p = 0,039) a 60 dB y en la discriminación de la palabra en G1 vs. G2 (p = 0,009) y G1 vs. G3 (p = 0,013). Conclusiones: En el grupo estudiado existe pérdida auditiva relacionada con un consumo diario a partir de los 40g de alcohol, siendo el oído más afectado el izquierdo, en las frecuencias medias y agudas, en la cóclea y el tronco cerebral.

Abstract Objective: To analyze the relationship between alcohol consumption and loss hearing in women between 20 and 40 years of age in Temuco city. Methodology: Cutting study. We evaluated 30 consuming and non alcoholic women divided into 3 groups (G): G1 abstemies, G2 consumers of 40-59 and G3 consumers of> 60 grams alcohol daily (15, 6 and 9 respectively), intentional sampling contacted in shopping centers. Auditory tests were performed: Audiometry, Discrimination of the Word and Auditory Evoked Potentials of the Brain Stem. Results: In the right ear, there were significant differences in medium frequencies and word discrimination between groups 1 versus 2 (p = 0.045 and 0.010, respectively). In left ear, there were significant differences in the high frequencies between groups 1 versus 3, interpeak latencies of iii-v waves (time elapsed between iii and v waves in millisecond after the stimulus) between groups 1 versus 2 (p = 0.003) and groups 2 versus 3 (p = 0.005) to 80 dB; in interpeak latencies i-iii and iii-vbetween groups 1 versus 2 (p = 0.039) at 60 dB and in word discrimination between groups 1 versus 2 (p = 0.009) and 1 versus 3 (p = 0.013). Conclusion: In the group studied there is hearing loss related to a daily consumption from the 40 grams of alcohol being the most affected ear the left in the medium and high frequencies and affecting to the cochlea and also brainstem.

Resumo Objetivo: O objetivo foi analisar a relação entre consumo de álcool e perda auditiva em mulheres entre 20 e 40 anos. Metodologia: Foi realizado um estudo transversal não experimental em que 30 consumidoras femininas e não o álcool foram divididas em 3 grupos: abstêmios G1, consumidores G2 de 40-59 gramas e consumidores G3> 60 gramas de álcool por dia. Testes auditivos foram realizados: audiometria, discriminação de palavras e potencial evocado auditivo de tronco encefálico. O teste não paramétrico de Mann-Whitney U foi utilizado para a análise estatística. Resultados: Na orelha direita, há diferenças significativas nas frequências médias e discriminação de palavras entre os grupos 1 e 2 (p = 0,045 e 0,010, respectivamente). Na orelha esquerda, há diferenças significativas nas freqüências agudas entre os grupos 1 versus 3, nas latências interpicos das ondas iii-v entre os grupos 1 versus 2 (p = 0,003) e os grupos 2 versus 3 (p = 0,005) a 80dB; nas latências interpicos i-iii e iii-v entre os grupos 1 versus 2 (p = 0,039) a 60 dB e na discriminação de palavras entre os grupos 1 versus 2 (p = 0,009) e 1 versus 3 (p = 0,013). Conclusões: Há uma perda auditiva relacionada ao consumo diário de 40 gramas de álcool, sendo que a orelha mais afetou a esquerda nas freqüências média e aguda, afetando a cóclea e o tronco cerebral.

Mortality in the Americas from 2013 to 2015 resulting from diseases, conditions and injuries which are 100% alcohol-attributable.

AIMS: To describe mortality in the Americas from 2013 to 2015 inclusive resulting from diseases, conditions and injuries which are 100% attributable to alcohol consumption. DESIGN AND SETTING: Mortality registry, population-based study. The data come from 30 of the 35 countries of the Americas for the triennium of 2013 to 2015. PARTICIPANTS AND CASES: A total of 18 673 791 deaths coded by three-digit ICD-10 codes were analyzed. MEASUREMENTS: Cause (underlying), and age-specific and age-adjusted mortality rates were calculated by sex and country. FINDINGS: From 2013 to 2015 inclusive, among 30 of the 35 countries of the Americas, an average of 85 032 deaths per year were entirely attributable to alcohol. Men accounted for 83.1% of all 100% alcohol-attributable deaths, and death rates were higher for men than for women across all countries; however, the ratios of 100% alcohol-attributable deaths by sex varied by country. The majority of all 100% alcohol-attributable deaths occurred among those aged under 60 years (64.9%) and were due to liver disease (63.9%) followed by neuropsychiatric disorders (27.4%). Age-adjusted 100% alcohol-attributable mortality rates were highest in Nicaragua (23.2 per 100 000) and Guatemala (19.0 per 100 000), although the majority of all 100% alcohol-attributable deaths occurred in the United States 36.9%), Brazil (24.8%), and Mexico (18.4%). CONCLUSIONS: From 2013 to 2015, more than 85 000 deaths in the Americas were 100% attributable to alcohol. Most of those occurred in people under 60 years and the highest mortality rates occurred in the United States, Brazil and Mexico.

Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?

BACKGROUND: The Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) is commonly used in hospitals to titrate medications for alcohol withdrawal syndrome (AWS), but may be difficult to apply to intensive care unit (ICU) patients who are too sick or otherwise unable to communicate. OBJECTIVES: To evaluate the frequency of CIWA-Ar monitoring among ICU patients with AWS and variation in CIWA-Ar monitoring across patient demographic and clinical characteristics. METHODS: The study included all adults admitted to an ICU in 2017 after treatment for AWS in the Emergency Department of an academic hospital that standardly uses the CIWA-Ar to assess AWS severity and response to treatment. Demographic and clinical data, including Richmond Agitation-Sedation Scale (RASS) assessments (an alternative measure of agitation/sedation), were obtained via chart review. Associations between patient characteristics and CIWA-Ar monitoring were tested using logistic regression. RESULTS: After treatment for AWS, only 56% (n = 54/97) of ICU patients were evaluated using the CIWA-Ar; 94% of patients had a documented RASS assessment (n = 91/97). Patients were significantly less likely to receive CIWA-Ar monitoring if they were intubated or identified as Black. CONCLUSIONS: CIWA-Ar monitoring was used inconsistently in ICU patients with AWS and completed less often in those who were intubated or identified as Black. These hypothesis-generating findings raise questions about the utility of the CIWA-Ar in ICU settings. Future studies should assess alternative measures for titrating AWS medications in the ICU that do not require verbal responses from patients and further explore the association of race with AWS monitoring.

Binge drinking e fatores associados em indígenas da etnia Karipuna / Binge drinking and associated factors in indigenous people from Karipuna / Binge drinking y factores asociados en indígenas de la etnia Karipuna

OBJETIVO: identificar a prevalência do uso em binge em indígenas Karipuna e verificar a associação desse uso com variáveis sociodemográficas, clínicas e comportamentais da amostra. MÉTODO: trata-se de um estudo transversal realizado com 230 indígenas de 12 aldeias Karipuna em Oiapoque. Obteve-se o rastreio do uso em binge por meio da Questão-Chave. Coletaram-se os dados entre maio e dezembro de 2017. Realizaram-se, a priori, a análise de frequência das variáveis envolvidas no estudo e, na sequência, o teste qui-quadrado e o modelo de regressão logística. RESULTADOS: revela-se que a prevalência do uso em binge foi de 24,8% de uma a três vezes; de 20,4% de quatro a seis vezes; de 12,2% de sete a dez vezes e de 9,6% em mais de dez vezes. Associaram-se os seguintes fatores: estudante (OR=2,99); migração da aldeia de origem (OR=2,22); uso de preservativo (OR=2,62) e relações sexuais após o consumo de álcool (OR=1,61). CONCLUSÃO: alerta-se que o uso ocasional de risco de álcool demanda consideração, bem como o conhecimento das particularidades da população ora investigada, a fim de estabelecer controle, planejamento de recursos terapêuticos para que se alcancem resultados efetivos nas ações planejadas e principalmente nas que são adotadas na prática a fim de prevenir um uso abusivo de álcool.

OBJECTIVE: to identify the prevalence of use in binge in indigenous Karipuna and to verify the association of this use with sociodemographic, clinical and behavioral variables of the sample. METHOD: this is a cross-sectional study carried out with 230 indigenous people from 12 Karipuna villages in Oiapoque. Binge use screening was obtained through the Key Question. Data was collected between May and December 2017. A priori, the frequency analysis of the variables involved in the study was carried out, following the chi-square test and logistic regression model. RESULTS: it is revealed that the prevalence of use in binge was 24.8% from one to three times; 20.4% four to six times; 12.2% seven to ten times and 9.6% more than ten times. The following factors were associated: student (OR = 2.99); migration from the village of origin (OR = 2.22); condom use (OR = 2.62) and sexual intercourse after alcohol consumption (OR = 1.61). CONCLUSION: it is warned that the occasional use of alcohol risk demands consideration, as well as knowledge of the particularities of the population now investigated, in order to establish control, planning of therapeutic resources so that effective results are achieved in the planned actions and especially in those that are adopted in practice in order to prevent alcohol abuse.

OBJETIVO: identificar la prevalencia del uso de binge en indígenas Karipuna y verificar la asociación de este uso con las variables sociodemográficas, clínicas y comportamentales de la muestra. MÉTODO: se trata de un estudio transversal realizado con 230 indígenas de 12 aldeas Karipuna en Oiapoque. Se obtuvo el rastreo del uso de binge por medio de la pregunta clave. Se recogieron los datos entre los meses de mayo y diciembre de 2017. Se realizaron, a priori, el análisis de la frecuencia de las variables del estudio y a continuación se realizó el test chi-cuadrado y el modelo de regresión logístico. RESULTADOS: se revela que la prevalencia del uso de binge fue de 24,8% de una a tres veces; de 20,4% de cuatro a seis veces; de 12,2% de siete a diez veces y de 9,6% en más de diez veces. Se asociaron los siguientes factores: estudiante (OR=2,99); migración de la aldea de origen (OR=2,22); uso de preservativo (OR=2,62) y relaciones sexuales después de consumo de alcohol (OR=1,61). CONCLUSIÓN: se advierte que el uso ocasional de riesgo de alcohol demanda atención, así como tomar conocimiento de las particularidades de la población que está siendo investigada, con la finalidad de establecer control y planificar recursos terapéuticos, para que sean alcanzados resultados efectivos, en las acciones planificadas y, principalmente, en aquellas que son adoptadas en la práctica, con la finalidad de prevenir el uso abusivo del alcohol.

Factors influencing the implementation of screening and brief interventions for alcohol use in primary care practices: a systematic review using the COM-B system and Theoretical Domains Framework.

BACKGROUND: Alcohol is a leading risk factor contributing to the global burden of disease. Several national and international agencies recommend that screening and brief interventions (SBI) should be routinely delivered in primary care settings to reducing patients' alcohol consumption. However, evidence shows that such activities are seldom implemented in practice. A review of the barriers and facilitators mediating implementation, and how they fit with theoretical understandings of behaviour change, to inform the design of implementation interventions is lacking. This study aimed to conduct a theory-informed review of the factors influencing general practitioners' and primary care nurses' routine delivery of alcohol SBI in adults. METHODS: A systematic literature search was carried out in four electronic databases (Medline, CINAHL, CENTRAL, PsycINFO) using comprehensive search strategies. Both qualitative and quantitative studies were included. Two authors independently abstracted and thematically grouped the data extracted. The barriers and facilitators identified were mapped to the domains of the Capability-Opportunity-Motivation-Behaviour system/Theoretical Domains Framework (TDF). RESULTS: Eighty-four out of the 258 studies identified met the selection criteria. The majority of the studies reported data on the views of general practitioners (n = 60) and used a quantitative design (n = 49). A total of 660 data items pertaining to barriers and 253 data items pertaining to facilitators were extracted and thematically grouped into 46 themes. The themes mapped to at least one of the 14 domains of the TDF. The three TDF domains with the highest number of data units coded were 'Environmental Context and Resources' (n = 158, e.g. lack of time), 'Beliefs about Capabilities' (n = 134, e.g. beliefs about the ability to deliver screening and brief advice and in helping patients to cut down) and 'Skills' (n = 99, e.g. lack of training). CONCLUSIONS: This study identified a range of potential barriers and facilitators to the implementation of alcohol SBI delivery in primary care and adds to the scarce body of literature that identifies the barriers and facilitators from a theoretical perspective. Given that alcohol SBI is seldom implemented, this review provides researchers with a tool for designing novel theory-oriented interventions to support the implementation of such activity. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016052681.